Navigation Links
VirtualScopics, Inc. Reports a Record Breaking Quarter
Date:8/12/2009

er similarly titled measures used by other companies. The Company continues to provide information in accordance with GAAP, however, with the adoption of EITF 07-05 and the non-cash variable nature of stock compensation expense and their very substantial impact on the overall reported net losses, the Company believes it is also helpful for investors to receive additional information relating more specifically to the Company's operating results. Accordingly, the Company has presented Adjusted EBITDA which excludes the non-cash effects of EITF 07-05 and FAS 123R on its financial results. Management uses Adjusted EBITDA (a) to evaluate the Company's financial performance, (b) to set internal spending budgets, and (c) to measure operational profitability. In addition, investors have requested these non-GAAP financial measures as a means of providing consistent and comparable information with past reports of financial results. Pursuant to the requirements of Regulation G, the Company has provided a reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure, net loss, below.

About VirtualScopics, Inc.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009
2. BELLUS Health reports results for first half of fiscal 2009
3. China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates
4. VIVUS Reports Second Quarter 2009 Financial Results
5. Mesa Labs Reports Higher First Quarter Earnings
6. Physician Owned and Operated Hospitals Get Top Rankings From Consumer Reports, but They Remain on the Healthcare Reform Chopping Block
7. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
8. Winner Medical Reports Third Quarter Fiscal 2009 Results
9. Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
10. DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
11. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 Global prebiotics market is expected ... a new study by Grand View Research, Inc. Positive ... sugar and fat free products owing to increased concerns ... prebiotics over the forecast period. , View full report ... & beverage was the largest application segment with market ...
(Date:10/30/2014)... October 30, 2014 The human brain ... more vigorously exercised to help maintain better mental health, ... book ‘Dementia Express: Lose Your Memory in 100 Ways’ ... reasoning and sometimes conflicting attitudes to help keep the ... mind, a reader must decipher the hidden logic within. ...
(Date:10/30/2014)... Sound Telecom, a leader in the call center industry, ... time they wonder, “Should I use an answering service?” The ... through a series of yes or no questions that ultimately ... are many considerations and scenarios that come into play when ... . This decision infographic serves as a bit of a ...
(Date:10/30/2014)... Amy Norton HealthDay Reporter ... common plastics, chemical during pregnancy may have effects on genital ... found that baby boys born to moms with greater exposure ... anogenital distance -- the space between the genitals and anus. ... a marker of exposure to androgens ("male" hormones) during pregnancy. ...
(Date:10/30/2014)... 2014 (HealthDay News) -- Eating a low-carb, high-fat diet ... according to new research. A review of ... diet, that focuses on foods like bacon, eggs, heavy ... seizures in adults whose condition doesn,t improve with medication. ... of people with epilepsy whose seizures are not stopped ...
Breaking Medicine News(10 mins):Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... Healthcare ( www.siemens.com/healthcare ) ... the Workflow & Solutions Division, Siemens Healthcare, testified before the ... Representatives on the need for healthcare reform. ... ) , , During the hearing, "Comprehensive Health ...
... , Supporting individual quality of life and American business ... 24 The U.S. Women,s Chamber of Commerce submitted ... to restore American values and business competitiveness through the ... report include the support of Health Insurance Exchanges, guaranteed ...
... Inc. (NYSE: WPI ), a leading specialty ... Inc., has received approval today from the United States ... Application (ANDA) for levonorgestrel tablets, 0.75 mg, for women ... equivalent to Duramed Pharmaceuticals, PLAN B(R), which is indicated ...
... memories , WEDNESDAY, June 24 (HealthDay News) -- Researchers ... long-term storage of memories. , Their study showed that ... remember them less well than mice who can perform ... Circuit Genetics at MITs Picower Institute for Learning and ...
... shows better survival when compared to those who ... News) -- A new Canadian study adds compelling ... get clot-dissolving treatment for heart attacks should have ... "This study strengthens the guideline recommendations," said Dr. ...
... Mich., June 24 Validation and Compliance Institute (VCI), ... FDA regulated industries, will offer a series of Dietary ... (DBA), a division of NSF International. , ... the new GMP regulations for dietary supplements, which the ...
Cached Medicine News:Health News:Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 2Health News:Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 3Health News:U.S. Women's Chamber of Commerce Advocates Strong Healthcare Reforms in Support of American Values 2Health News:Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R) 2Health News:Sleep May Be Essential for Long-Term Memory 2Health News:Quick Angioplasty Best After Heart Attacks 2Health News:Quick Angioplasty Best After Heart Attacks 3Health News:Validation & Compliance Institute, LLC, to Provide Dietary Supplement GMP Training for NSF International 2
(Date:10/30/2014)... YORK , Oct. 30, 2014  The number ... States is growing steadily, thanks to drug ... as a result of the economic downturn, retail clinic ... a year of opportunities, as the number of retail ... researcher,s report, Retail Clinics Market Overview and 2014 ...
(Date:10/30/2014)... 30, 2014 Molecular Profiles Ltd., a subsidiary ... and Maryland -based Xceleron have announced ... during clinical development that will be launched at AAPS ... This partnership extends Molecular Profiles, new ROADMAP ... earlier this month. The company also has complementary collaborations ...
(Date:10/30/2014)... Oct. 30, 2014  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced an upcoming ... drug candidate, aldoxorubicin.  The presentation, titled, "Drug Conjugates ... be given by Sant P. Chawla , ... and principal investigator of the Company,s ongoing global, ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
BD Vacutainer® Fluoride Tubes - Glass...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: